Discover the groundbreaking scientific research that utilizes CRISPR technology.

Reading time: 7 min
WhatsApp ↗
Health Portal · Brazil Without Allergies Project

Discover the groundbreaking scientific research that utilizes CRISPR technology.

USE OF CRISPR TECHNOLOGY IN THE FIGHT AGAINST COVID-19

CRISPR technology is being applied in scientific research with the participation of ABBAA. Learn more about CRISPR and how it can revolutionize global health.

 

YouTube video player
 
Watch all the videos in the playlist about CRISPR against Covid-19.
 

SEE OTHER VIDEOS ON THIS TOPIC

 

 

CRISPR is a gene-editing technology that is poised to revolutionize medicine!

Researchers are developing CRISPR therapies for a wide range of diseases, including inherited eye diseases, neurodegenerative conditions such as Alzheimer's and Huntington's diseases, and non-inherited diseases such as cancer and HIV.
In fact, human trials of CRISPR are already underway for many of these diseases.

How can CRISPR be used to cure diseases?

Brazil Without Allergies Project - Discover the innovative scientific research that uses CRISPR technology.Using the CRISPR system, researchers can precisely edit any target DNA locus—a feat that was not possible with other gene-editing tools.

The possibility of editing a disease mutation to correct genetic errors creates opportunities for treating diseases that have long eluded the medical research community.

We at the Brazil Without Allergies project are part of this select research group. In partnership with international universities and Brazilian research institutes, we are developing scientific research and validating CRISPR technology tests for the rapid, inexpensive, and effective identification (hours after infection) of SARS-CoV-2 (COVID-19). Follow our social media for research updates.

Visit our locations at Duque de Caxias (Rio de Janeiro state), Nova Iguaçu (Rio de Janeiro state), Realengo - Rio de Janeiro, Itaguaí - Rio de Janeiro, Iguaba Grande - State of Rio de Janeiro (Red Cross) and Xerém To learn more about our project and its range of services,

CRISPR can cure several genetic diseases, from hereditary diseases like sickle cell anemia to cancer. The list of diseases currently being treated with CRISPR grows every day! Research has not stopped even with the emergence of COVID-19. COVID-19 did not reduce the flow of patients seeking treatment at our units in Duque de Caxias (Rio de Janeiro state), Nova Iguaçu (Rio de Janeiro state), Realengo - Rio de Janeiro, Itaguaí - Rio de Janeiro, Iguaba Grande - Rio de Janeiro state (Red Cross) and Xerém (mainly in Duque de Caxias). The search for a body balance with a reduction in symptoms of respiratory allergies, dermatological or food This is proving very important for strengthening the immune system node combating opportunistic infectionsincluding COVID-19.

 

Schedule your appointment

RIO DE JANEIRO
Telephone: +55 (21) 4063-8720
WhatsApp: +55 (21) 99954-5632

CURITIBA
Telephone: +55 (41) 3542-1838

 


 

IT WAS IN THE MEDIA

Canadian scientist makes innovative technique for detecting and treating coronavirus available to Brazil.

Canadian scientist Dr. Jacques Tremblay warns about the urgency of COVID-19. Tremblay is a professor in the Department of Molecular Medicine at Laval University and a researcher at the Laval University Hospital Center, Quebec.

Dr. Jacques' team is committed to developing innovative methods for detecting and treating the Coronavirus based on CRISPR technology. Following the tragic scenario caused by the disease, collaboration between governments and researchers worldwide is more necessary than ever. This is something Professor Tremblay is therefore trying to establish with various countries, including Brazil. This collaboration can greatly help reduce the impact of the epidemic. He emphasizes the importance of this integration in solving the problems caused by COVID-19, which has already infected hundreds of thousands of people worldwide.

Regarding the research, the professor emphasizes that the current method for detecting COVID-19 in most countries is RT-PCR. This method is based on reverse transcriptase and polymerase chain reaction. It requires trained technicians and limited laboratory equipment. He suggests that this method could be replaced by a new, simpler, and more efficient one that does not require dedicated technical professionals and equipment, thus limiting the number of tests performed and delaying disease diagnosis. The potential new technique mentioned is CRISPR, which has existed since 2017 and is much faster and may be more appropriate as it would facilitate the detection of viral infections and could be used by many clinics throughout Brazil.

Tremblay says that Sherlock's new test is as simple as a pregnancy test. It uses a simple cardboard strip, and the appearance of a black band indicates a positive result. Therefore, it is cheaper than the RT-PCR test currently used. Furthermore, it can be used directly in any clinic without technical training or expensive equipment. Regarding Brazil, he says he would like to collaborate with Brazilian researchers from the immunology unit of the Santa Casa da Misericórdia hospital in Rio de Janeiro to develop this detection technology and, subsequently, a treatment for COVID-19.

Professor Tremblay is making the Research Center of the University of Quebec-Université Laval available through the immunology unit of the Santa Casa Hospital and says he would like to collaborate with Brazilian scientists during this time of international crisis in which researchers from all countries should collaborate as much as possible.